In honor of its former Chairman of the Board, the FNIH celebrates its partners through the Charles A. Sanders, MD, Partnership Award. The award recognizes persons or organizations that have made significant contributions to the FNIH’s work to build, implement, and nurture private-public partnerships in support of the mission of the NIH.

The prizes was awarded at the FNIH 11th Annual Awards Ceremony on October 18, 2023, in Washington, DC.

Please contact the Advancement Office for more information at [email protected].

2023 Award Recipients

Selection Committee

The Partnership Award recipients are selected by a committee comprised of the following FNIH Board members:

  • Charles A. Sanders, MD 
  • Steven M. Paul, MD 
  • Thomas R. Insel, MD 
  • Judy Lansing Kovler, PhD 
  • Mr. Fred A. Seigel 
  • Solomon H. Snyder, MD 

Previous Recipients

  • Director
    2022
    Francis Collins, MD, PhD

    Dr. Francis Collins robustly supported the mission of the FNIH during his tenure as NIH Director, advancing a remarkable list of initiatives. His work as Director of the National Human Genome Research Institute expanded the promise of DNA in medical research, enabling the FNIH’s first major partnership with the institute and the Genetic Association Information Network to create a significant resource for genetic researchers.

    Learn More
  • Director
    2022
    Amgen

    Over many years, Amgen’s partnership with FNIH has had a strong impact on several initiatives, from clinical trials to mentorships to educational programs. Amgen has provided generous financial and scientific support to the FNIH’s research programs in cancer, immunotherapy, cardiometabolic disease, and precision medicine. Amgen has also supported major projects for lung cancer and lymphoma, precision analysis of clinical trial results, and acceleration of cancer therapies.

    Learn More
  • Director
    2021
    Janssen Research & Development, LLC 

    Janssen Research & Development, LLC, has been an exemplary partner and leader across many FNIH projects and programs, including ACTIV; several Accelerating Medicines Partnerships®; the Biomarkers Consortium; the Partnership for Accelerating Cancer Therapies (PACT); and the Alzheimer’s Disease Neuroimaging Initiative (ADNI).

    Learn More
  • Director
    2021
    Co-Chairs of the Accelerating COVID-19 Therapeutic Interventions and Vaccines (ACTIV) Working Groups 

    The Working Group Co-Chairs participated in hundreds of meetings, reporting regularly to the ACTIV Leadership Team, and devoted valuable time and effort to identify opportunities for and help resolve challenges to the partnership. They have been invaluable to the ability of ACTIV to navigate the ever-changing scientific and political landscape during this all-encompassing global pandemic.

    Learn More
  • Director
    2020
    Dr. Anthony S. Fauci  

    Dr. Fauci was honored for his legacy of leadership and ongoing support of FNIH programs propelling research in lethal infectious diseases, most recently for Covid-19.

    Learn More
  • Director
    2019
    The Doris Duke Charitable Foundation (DDCF) and Jane Sayer, PhD

    DDCF and Dr. Jane Sayer were recognized for their longstanding support in advancing transformative NIH training and awards programs that empower future and current researchers, in addition to helping further the mission of the Foundation.

    Learn More
  • Director
    2018
    Andrew Lee

    Through his unwavering commitment to advancing biomedical research on rare kidney cancers, in just over two years, Andrew, President & CEO of Driven the Cure, has developed a powerful grassroots movement that has increased visibility about rare kidney cancers and raised funds for the FNIH to further cutting-edge research conducted by the National Cancer Institute (NCI) at the NIH Clinical Center.

    Learn More
  • Director
    2017
    Richard J. Hodes, MD and Eli Lilly & Company 

    Through their longstanding work with the FNIH over more than a decade, Dr. Hodes and Lilly have advanced trailblazing biomedical research in critical disease areas, including age-related disorders such as Alzheimer’s disease, and helped structure innovative public-private partnerships.

    Learn More
  • Director
    2016
    Bill & Melinda Gates Foundation and Pfizer 

    The Bill & Melinda Gates Foundation was recognized for its longstanding and generous partnership with the FNIH, which has spurred scientific and technical innovations leading to transformative advances in global health research. Pfizer was recognized for its unwavering and sustained commitment for nearly two decades as a vital partner to the FNIH in funding scientific programs that have laid the groundwork for biomedical breakthroughs.

    Learn More

Donate

Lorem ipsum dolor sit amet, consectetur adipiscing elit.

Partner With Us

Work with the FNIH to accelerate medical breakthroughs for patients